|
Apr 25
|
Bristol Myers posts quarterly loss, revenue rises 5%
|
|
Apr 25
|
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
|
|
Apr 25
|
Bristol Myers to cut 6% of workforce, trim drug pipeline
|
|
Apr 24
|
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
|
|
Apr 24
|
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
|
|
Apr 23
|
NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 23
|
Former Bristol Myers CEO tapped as Novartis’ next board chair
|
|
Apr 22
|
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
|
|
Apr 22
|
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Apr 22
|
Bristol Myers taps startup to boost cell therapy production
|
|
Apr 22
|
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
|
|
Apr 21
|
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt?
|
|
Apr 20
|
3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations
|
|
Apr 19
|
Got $500? 3 Healthcare Stocks to Buy and Hold Forever
|
|
Apr 18
|
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
|
|
Apr 17
|
3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500
|
|
Apr 17
|
2 High-Yield Dividend Stocks to Buy and Hold for 10 Years
|
|
Apr 15
|
3 Pharma Stocks That Are Money-Printing Machines in 2024
|
|
Apr 15
|
Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
|
|
Apr 15
|
In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$5.7b market cap drop, institutional owners may be forced to take severe actions
|